Featuring:
- Sandy Balkin, Royalty Pharma
- Stephen Lynch, AlphaSense
GenAI and the Next Era of Diligence: Speed, Scale, and Security
Explore more
Agentic Intelligence: Transforming High-Stakes Diligence
Corey Hammill, AlphaSense Andy Pierce, AlphaSense
Patrick O'Shaughnessy & Keith Weiss
Keith Weiss - Head of U.S. Software Research, Morgan Stanley Patrick O'Shaughnessy - Partner and CEO, Positive Sum
Policy Shifts Reshaping Biopharma: IRA, PBM Reform, and Beyond
Watch this session for a breakdown of the policy developments that matter most for biopharma leaders—what’s changing, how it may impact the industry, and the strategies companies are deploying to adapt.
Transform intelligence
into advantage
Develop bold strategies, seize opportunities, and lead with clarity and confidence.